It has been also reported that VEGF overexpression is an indicator of poor prognosis in breast carcinoma, lung cancer, and hematopoietic malignancies [41–43]; however, the correlation between VEGF expression in NHL and patient prognosis remains unclear. This evidence concerns the gene VEGFA and breast carcinoma.